Suggestions
Gilbert Wagener
Senior Vice President and Chief Medical Officer at Ixaka
Dr. Gilbert Wagener is a highly accomplished professional with a diverse background in clinical development of small molecules and biologics in various disease domains. With expertise spanning from phase I to phase IV trials, Dr. Wagener specializes in cardiovascular, immune-mediated, neurological, and orphan diseases, including the development and affordability of gene therapy for monogenic orphan diseases. His skills encompass clinical trial design, evidence-based medicine, and translating research into clinical practice. Additionally, he has a keen interest in fostering partnerships between industry and academia, particularly in the realm of clinical development. Dr. Wagener's contributions also extend to addressing cardiovascular disease treatment strategies for underserved regions.
